|
1
|
Epstein JI, Egevad L, Amin MB, Delahunt B,
Srigley JR and Humphrey PA: Grading Committee: The 2014
International society of urological pathology (ISUP) consensus
conference on gleason grading of prostatic carcinoma: Definition of
grading patterns and proposal for a new grading system. Am J Surg
Pathol. 40:244–252. 2016.PubMed/NCBI
|
|
2
|
Epstein JI, Allsbrook WC Jr, Amin MB and
Egevad LL: ISUP Grading Committee: The 2005 International Society
of Urological Pathology (ISUP) consensus conference on Gleason
grading of prostatic carcinoma. Am J Surg Pathol. 29:1228–1242.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Freedman ND, Silverman DT, Hollenbeck AR,
Schatzkin A and Abnet CC: Association between smoking and risk of
bladder cancer among men and women. Jama. 306:737–745. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu
Z, Stass SA and Jiang F: Aldehyde dehydrogenase 1 A1-positive cell
population is enriched in tumor-initiating cells and associated
with progression of bladder cancer. Cancer Epidemiol Biomarkers
Prev. 19:327–337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ren J, Kan A, Leong SH, Ooi LL, Jeang KT,
Chong SS, Kon OL and Lee CG: FAT10 plays a role in the regulation
of chromosomal stability. J Biol Chem. 281:11413–11421. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Chen L, Ge J, Yan C, Huang Z, Hu J,
Wen C, Li M, Huang D, Qiu Y, et al: The ubiquitin-like protein
FAT10 stabilizes eEF1A1 expression to promote tumor proliferation
in a complex manner. Cancer Res. 76:4897–4907. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong D, Jiang W, Lei J, Chen L, Liu X, Ge
J, Che B, Xi X and Shao J: Ubiquitin-like protein FAT10 promotes
bladder cancer progression by stabilizing survivin. Oncotarget.
7:81463–81473. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mori K, Enokida H, Kagara I, Kawakami K,
Chiyomaru T, Tatarano S, Kawahara K, Nishiyama K, Seki N and
Nakagawa M: CpG hypermethylation of collagen type I alpha 2
contributes to proliferation and migration activity of human
bladder cancer. Int J Oncol. 34:1593–1602. 2009.PubMed/NCBI
|
|
10
|
Chiyomaru T, Enokida H, Kawakami K, et al:
Functional role of LASP1 in cell viability and its regulation by
microRNAs in bladder cancer. Urologic Oncology: Seminars and
Original Investigations Elsevier. 434–443. 2012. View Article : Google Scholar
|
|
11
|
Wang C, Zhang L, He Q, Feng X, Zhu J, Xu
Z, Wang X, Chen F, Li X and Dong J: Differences in yes-associated
protein and mRNA levels in regenerating liver and hepatocellular
carcinoma. Mol Med Rep. 5:410–414. 2012.PubMed/NCBI
|
|
12
|
Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo
Z, Dong W, Huang J and Lin T: MicroRNA-125b suppresses the
development of bladder cancer by targeting E2F3. Int J Cancer.
128:1758–1769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshino H, Chiyomaru T, Enokida H,
Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa
M: The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor alpha
mediates proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghosh RD, Ghuwalewala S, Das P, Mandloi S,
Alam SK, Chakraborty J, Sarkar S, Chakrabarti S, Panda CK and
Roychoudhury S: MicroRNA profiling of cisplatin-resistant oral
squamous cell carcinoma cell lines enriched with
cancer-stem-cell-like and epithelial-mesenchymal transition-type
features. Sci Rep. 6:239322016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu Q, Liu Y, Wen C, Zhao Y, Jin S, Hu Y,
Wang F, Chen L, Zhang B, Wang W, et al: MicroRNA-1 inhibits
tumorigenicity of esophageal squamous cell carcinoma and enhances
sensitivity to gefitinib. Oncol Lett. 15:963–971. 2018.PubMed/NCBI
|
|
17
|
Cao Q, Lu K, Dai S, Hu Y and Fan W:
Clinicopathological and prognostic implications of the miR-200
family in patients with epithelial ovarian cancer. Int J Clin Exp
Pathol. 7:2392–2401. 2014.PubMed/NCBI
|
|
18
|
Metz CE: Basic principles of ROC
analysisSeminars in Nuclear Medicine. 8.4. Elsevier; New York, NY:
pp. 283–298. 1978, View Article : Google Scholar
|
|
19
|
Zweig MH and Campbell G:
Receiver-operating characteristic (ROC) plots: A fundamental
evaluation tool in clinical medicine. Clin Chem. 39:561–577.
1993.PubMed/NCBI
|
|
20
|
Lu DL, Sookthai D, Le Cornet C, Katzke VA,
Johnson TS, Kaaks R and Fortner RT: Reproducibility of serum
oxysterols and lanosterol among postmenopausal women: Results from
EPIC-Heidelberg. Clin Biochem. 52:117–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The mir-200 family and mir-205 regulate epithelial to mesenchymal
transition by targeting ZeB1 and sIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adam L, Zhong M, Choi W, Qi W, Nicoloso M,
Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, et al:
miR-200 expression regulates epithelial-to-mesenchymal transition
in bladder cancer cells and reverses resistance to epidermal growth
factor receptor therapy. Clin Cancer Res. 15:5060–5072. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ross MJ, Wosnitzer MS, Ross MD, Granelli
B, Gusella GL, Husain M, Kaufman L, Vasievich M, D'Agati VD, Wilson
PD, et al: Role of ubiquitin-like protein FAT10 in epithelial
apoptosis in renal disease. J Am Soc Nephrol. 17:996–1004. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gong P, Canaan A, Wang B, Leventhal J,
Snyder A, Nair V, Cohen CD, Kretzler M, D'Agati V, Weissman S and
Ross MJ: The ubiquitin-like protein FAT10 mediates NF-kappaB
activation. J Am Soc Nephrol. 21:316–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Canaan A, DeFuria J, Perelman E, Schultz
V, Seay M, Tuck D, Flavell RA, Snyder MP, Obin MS and Weissman SM:
Extended lifespan and reduced adiposity in mice lacking the FAT10
gene. Proc Natl Acad Sci USA. 111:5313–5318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu L, Dong Z, Liang J, Cao C, Sun J, Ding
Y and Wu D: As an independent prognostic factor, FAT10 promotes
hepatitis B virus-related hepatocellular carcinoma progression via
Akt/GSK3β pathway. Oncogene. 33:909–920. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun GH, Yu G, Li N, Sun X and Yang J:
Increased FAT10 expression is related to poor prognosis in
pancreatic ductal adenocarcinoma. Tumour Biol. 35:5167–5171. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Savagner P, Yamada KM and Thiery JP: The
zinc-finger protein slug causes desmosome dissociation, an initial
and necessary step for growth factor-induced epithelial-mesenchymal
transition. J Cell Biol. 137:1403–1419. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Wang Z, Yu J, Shi Jz, Wang C, Fu
Wh, Chen Zw and Yang J: Cancer stem-like cells contribute to
cisplatin resistance and progression in bladder cancer. Cancer
Lett. 322:70–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Friel AM, Sergent PA, Patnaude C, Szotek
PP, Oliva E, Scadden DT, Seiden MV, Foster R and Rueda BR:
Functional analyses of the cancer stem cell-like properties of
human endometrial tumor initiating cells. Cell Cycle. 7:242–249.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ismaili N, Amzerin M and Flechon A:
Chemotherapy in advanced bladder cancer: Current status and future.
J Hematol Oncol. 4:352011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu ZY, Tang JN, Xie HX, Du YA, Huang L, Yu
PF and Cheng XD: 5-Fluorouracil chemotherapy of gastric cancer
generates residual cells with properties of cancer stem cells. Int
J Biol Sci. 11:284–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fernando RI, Litzinger M, Trono P,
Hamilton DH, Schlom J and Palena C: The T-box transcription factor
Brachyury promotes epithelial-mesenchymal transition in human tumor
cells. J Clin Invest. 120:533–544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leskelä S, Leandro-García LJ, Mendiola M,
Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo
A, de Santiago J, Robledo M, et al: The miR-200 family controls
beta-tubulin III expression and is associated with paclitaxel-based
treatment response and progression-free survival in ovarian cancer
patients. Endocr Relat Cancer. 18:85–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li J, Feng Q, Kim JM, Schneiderman D,
Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, et
al: Human ovarian cancer and cisplatin resistance: Possible role of
inhibitor of apoptosis proteins. Endocrinology. 142:370–380. 2001.
View Article : Google Scholar : PubMed/NCBI
|
